Mark Shlomovich

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/f00957b0-d372-11ed-b9ca-f36b2b5dc5fe.jpg

First Name

Mark

Last Name

Shlomovich

NPI

1790065910

Faculty ID

15549

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Areas

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Elsevier Profile

EMR ID

29419

Biography

<p>Mark Shlomovich, MD, is Director, Extracorporeal Liver Support and Director, Pediatric Critical Care Transport at Children&rsquo;s Hospital at Montefiore and Assistant Professor, Pediatrics at Montefiore-Einstein. Dr. Shlomovich&rsquo;s clinical focus is on the care of critically ill children with abdominal organ failure, transplantation and post-surgical care. He also focuses on the safe transportation of critically ill children.</p><p>In 2006, Dr. Shlomovich earned his Bachelor of Science in biology from Towson University. He then attended University of Connecticut School of Medicine earning his Doctor of Medicine in 2010. His postgraduate training began at SUNY Downstate Medical Center with a four-year pediatric residency, where he was Chief Pediatric Resident in his final year. He then came to Children's Hospital at Montefiore for a pediatric critical care fellowship, which he completed in 2017.</p><p>Dr. Shlomovich&rsquo;s research interests are in the use of artificial liver support technology, as well as the care of children in liver failure before and after transplantation. In addition, he investigates the safety and efficiency of the transportation of critically ill children. He has shared his research through peer-reviewed journals and abstracts, and is an ad hoc reviewer for BMC Nephrology.</p><p>Dr. Shlomovich is board certified in general pediatrics and pediatric critical care medicine. He is a member of the Society of Critical Care Medicine and the American Academy of Pediatrics.</p>

Is Open Scheduling

Off

Ariel L. Shiloh

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/4f28f3b0-3caf-11ec-80f7-67047826a941.jpg

First Name

Ariel

Last Name

Shiloh

NPI

1346561891

Faculty ID

12325

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p class="MsoNormal" style="background: white;">Dr. Shiloh is the Director of the Critical Care Medicine Consult Service and Professor of Medicine at Montefiore Medical Center/Albert Einstein College of Medicine. As a clinician-educator he serves as the director of critical care ultrasonography.&nbsp;&nbsp;</p>
<p class="MsoNormal" style="background: white;">After receiving his medical degree from the Medical School for International Health at Ben Gurion University of the Negev in 2005, he completed both his Internal Medicine residency and Critical Care Medicine fellowship at Montefiore Medical Center/Albert Einstein College of Medicine. Dr. Shiloh joined the Montefiore/Einstein Critical Care faculty in 2010.&nbsp;</p>
<p class="MsoNormal" style="background: white;">&nbsp;Dr. Shiloh is board-certified in:&nbsp;</p>
<p class="MsoNormal" style="background: white;">&middot;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Internal Medicine</p>
<p class="MsoNormal" style="background: white;">&middot;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Critical Care Medicine</p>
<p class="MsoNormal" style="background: white;">&middot;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Neurocritical Care</p>
<p class="MsoNormal" style="background: white;">&middot;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Hospice and Palliative Medicine</p>
<p class="MsoNormal" style="background: white;">As an active member of CHEST, Dr. Shiloh serves as faculty leader and co-chair for the Critical Care Ultrasound: Integration Into Clinical Practice course.&nbsp; He is an active contributor to CHEST&rsquo;s &ldquo;Better with Ultrasound&rdquo; and &ldquo;Ultrasound Corner&rdquo; series and a recipient of the &ldquo;Distinguished Chest Educator&rdquo; award.&nbsp;<span style="color: #262626; font-family: Verdana;">Award recipients represent the top 4% of CHEST&rsquo;s international faculty and are recognized for their achievements and long-term contributions to the design and delivery of CHEST education.</span></p>
<p class="MsoNormal" style="background: white;">Dr. Shiloh has authored over 50 original articles, co-edited the &ldquo;The 5-Minute ICU Consult&rdquo; published by Lippincott Williams &amp; Wilkins, and has authored over 15 book chapters. His areas of interest and research include use of point of care ultrasonography, early identification of critical illness, and critical care education and simulation training.&nbsp;</p>
<p class="MsoNormal" style="background: white;">&nbsp;</p>
<p class="MsoNormal" style="background: white;">&nbsp;</p>
<p class="MsoNormal" style="background: white;">&nbsp;</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Early Detection and Treatment of Critical Illness, Point Of Care Ultrasonography For The Evaluation Of Critical Illness, Advanced Airway Management

Research Focus

Dr. Shiloh's research includes the clinical use of point-of-care ultrasonography in critical illness, improvement of airway management, and cardiopulmonary resuscitation.

Elsevier Profile

Selected Publications

<p>1: Shah TE, Vij R, Kim YH, Shiloh AL. Sudden Unilateral Vision Loss in a Patient</p>
<p>Who Received Intravenous Thrombolytic Therapy. Chest. 2021 Dec;160(6):e669-e672.</p>
<p>doi: 10.1016/j.chest.2021.03.074. PMID: 34872684.</p>
<p>&nbsp;</p>
<p>2: Nauka PC, Chen JT, Shiloh AL, Eisen LA, Fein DG. Practice, Outcomes, and</p>
<p>Complications of Emergent Endotracheal Intubation by Critical Care Practitioners</p>
<p>During the COVID-19 Pandemic. Chest. 2021 Dec;160(6):2112-2122. doi:</p>
<p>10.1016/j.chest.2021.06.008. Epub 2021 Jun 15. PMID: 34139207; PMCID:</p>
<p>PMC8204844.</p>
<p>&nbsp;</p>
<p>3: Savel RH, Shiloh AL, Kupfer Y, Hope AA. The Complex Issue of Race and</p>
<p>Coronavirus Disease 2019 in the ICU. Crit Care Med. 2021 Mar 1;49(3):532-535.</p>
<p>doi: 10.1097/CCM.0000000000004766. PMID: 33616353.</p>
<p>&nbsp;</p>
<p>4: Jabbour E, Malik D, Shiloh AL. Sudden Cardiopulmonary Collapse in a Patient</p>
<p>With Coronavirus Disease 2019. Chest. 2021 Feb;159(2):e127-e129. doi:</p>
<p>10.1016/j.chest.2020.05.618. PMID: 33563455; PMCID: PMC7859694.</p>
<p>&nbsp;</p>
<p>5: Savel RH, Kupfer Y, Shiloh AL. Steady As She Goes: Practicing Evidence-Based</p>
<p>Critical Care When the Evidence Is Limited. Chest. 2021 Jan;159(1):7-8. doi:</p>
<p>10.1016/j.chest.2020.09.245. PMID: 33422231; PMCID: PMC7787062.</p>
<p>&nbsp;</p>
<p>6: Tirumandas M, Gendlina I, Figueredo J, Shiloh A, Trachuk P, Jain R, Corpuz M,</p>
<p>Spund B, Maity A, Shmunko D, Garcia M, Barthelemy D, Weston G, Madaline T.</p>
<p>Analysis of catheter utilization, central line associated bloodstream</p>
<p>infections, and costs associated with an inpatient critical care-driven vascular</p>
<p>access model. Am J Infect Control. 2021 May;49(5):582-585. doi:</p>
<p>10.1016/j.ajic.2020.10.006. Epub 2020 Oct 17. PMID: 33080360.</p>
<p>&nbsp;</p>
<p>7: Fein DG, Zhao D, Swartz K, Nauka P, Andrea L, Aboodi M, Shiloh AL, Eisen LA.</p>
<p>The Impact of Nighttime on First Pass Success During the Emergent Endotracheal</p>
<p>Intubation of Critically Ill Patients. J Intensive Care Med. 2021</p>
<p>Dec;36(12):1498-1506. doi: 10.1177/0885066620965166. Epub 2020 Oct 15. PMID:</p>
<p>33054483.</p>
<p>&nbsp;</p>
<p>8: Kapoor S, Chand S, Dieiev V, Fazzari M, Tanner T, Lewandowski DC, Nalla A,</p>
<p>Abdulfattah O, Aboodi MS, Shiloh AL, Gong MN. Thromboembolic Events and Role of</p>
<p>Point of Care Ultrasound in Hospitalized Covid-19 Patients Needing Intensive</p>
<p>Care Unit Admission. J Intensive Care Med. 2021 Dec;36(12):1483-1490. doi:</p>
<p>10.1177/0885066620964392. Epub 2020 Oct 6. PMID: 33021131; PMCID: PMC7539230.</p>
<p>&nbsp;</p>
<p>9: Emami N, Tanner T, Ogundipe F, Hawn VS, Rubin R, Skae CC, Shiloh AL, Keene</p>
<p>AB. Drape to prevent disease transmission during endotracheal intubation. Am J</p>
<p>Infect Control. 2021 Mar;49(3):387-388. doi: 10.1016/j.ajic.2020.06.212. Epub</p>
<p>2020 Jul 3. PMID: 32628982; PMCID: PMC7333628.</p>
<p>&nbsp;</p>
<p>10: Millington SJ, Colvin MO, Shiloh AL, Koenig S. How I Do It: Ultrasound-</p>
<p>Guided Internal Jugular and Femoral Central Venous Catheter Insertion. Chest.</p>
<p>2020 Dec;158(6):2425-2430. doi: 10.1016/j.chest.2020.06.026. Epub 2020 Jun 26.</p>
<p>PMID: 32599065.</p>
<p>&nbsp;</p>
<p>11: Savel RH, Shiloh AL, Saunders PC, Kupfer Y. Mechanical Ventilation During</p>
<p>the Coronavirus Disease 2019 Pandemic: Combating the Tsunami of Misinformation</p>
<p>From Mainstream and Social Media. Crit Care Med. 2020 Sep;48(9):1398-1400. doi:</p>
<p>10.1097/CCM.0000000000004462. PMID: 32496274; PMCID: PMC7302097.</p>
<p>&nbsp;</p>
<p>12: Shiloh AL, McPhee C, Eisen L, Koenig S, Millington SJ. Better With</p>
<p>Ultrasound: Detection of DVT. Chest. 2020 Sep;158(3):1122-1127. doi:</p>
<p>10.1016/j.chest.2020.01.038. Epub 2020 Feb 20. PMID: 32087215.</p>
<p>&nbsp;</p>
<p>13: Islam M, Levitus M, Eisen L, Shiloh AL, Fein D. Lung Ultrasound for the</p>
<p>Diagnosis and Management of Acute Respiratory Failure. Lung. 2020</p>
<p>Feb;198(1):1-11. doi: 10.1007/s00408-019-00309-1. Epub 2020 Jan 1. PMID:</p>
<p>31894411.</p>
<p>&nbsp;</p>
<p>14: Fein DG, Mastroianni F, Murphy CG, Aboodi M, Malik R, Emami N, Abramowitz M,</p>
<p>Shiloh AL, Eisen L. Impact of a Critical Care Specialist Intervention on First</p>
<p>Pass Success for Emergency Airway Management Outside the ICU. J Intensive Care</p>
<p>Med. 2021 Jan;36(1):80-88. doi: 10.1177/0885066619886816. Epub 2019 Nov 10.</p>
<p>PMID: 31707906.</p>
<p>&nbsp;</p>
<p>15: Millington SJ, Hendin A, Shiloh AL, Koenig S. Better With Ultrasound:</p>
<p>Peripheral Intravenous Catheter Insertion. Chest. 2020 Feb;157(2):369-375. doi:</p>
<p>10.1016/j.chest.2019.04.139. Epub 2019 Oct 22. PMID: 31654617.</p>
<p>&nbsp;</p>
<p>16: Wang A, Hendin A, Millington SJ, Koenig S, Eisen LA, Shiloh AL. Better With</p>
<p>Ultrasound: Arterial Line Placement. Chest. 2020 Mar;157(3):574-579. doi:</p>
<p>10.1016/j.chest.2019.08.2209. Epub 2019 Oct 18. PMID: 31634448.</p>
<p>&nbsp;</p>
<p>17: Savel RH, Shiloh AL, Simon RJ, Kupfer Y. Getting It Right for Our Patients:</p>
<p>The Importance of Collaborative Leadership in the ICU. Crit Care Med. 2019</p>
<p>Sep;47(9):1279-1281. doi: 10.1097/CCM.0000000000003880. PMID: 31415316.</p>
<p>&nbsp;</p>
<p>18: Islam M, Bangar M, Shiloh AL. A Woman in Her 70s on Anticoagulation With</p>
<p>Sudden Shock. Chest. 2019 May;155(5):e123-e126. doi:</p>
<p>10.1016/j.chest.2018.10.052. PMID: 31060707.</p>
<p>&nbsp;</p>
<p>19: Patrawalla P, Narasimhan M, Eisen L, Shiloh AL, Koenig S, Mayo P. A</p>
<p>Regional, Cost-Effective, Collaborative Model for Critical Care Fellows'</p>
<p>Ultrasonography Education. J Intensive Care Med. 2020 Dec;35(12):1447-1452. doi:</p>
<p>10.1177/0885066619828951. Epub 2019 Feb 12. PMID: 30755062.</p>
<p>&nbsp;</p>
<p>20: Shiloh AL. Smooth Transitions in Critical Care. J Emerg Trauma Shock. 2018</p>
<p>Jul-Sep;11(3):154-155. doi: 10.4103/JETS.JETS_44_17. PMID: 30429619; PMCID:</p>
<p>PMC6182967.</p>
<p>&nbsp;</p>
<p>21: Savel RH, Shiloh AL. Are We Really Doing More With Less: The Value of Half-</p>
<p>Dose Alteplase in Pulmonary Embolism Therapy. Crit Care Med. 2018</p>
<p>Oct;46(10):1696-1697. doi: 10.1097/CCM.0000000000003303. PMID: 30216306.</p>
<p>&nbsp;</p>
<p>22: Savel RH, Borgia D, Shiloh AL. A Path to High-Quality Care: Implementing</p>
<p>Flexible Visitation While Avoiding Staff Burnout. Crit Care Med. 2018</p>
<p>Jul;46(7):1203-1204. doi: 10.1097/CCM.0000000000003167. PMID: 29912108.</p>
<p>&nbsp;</p>
<p>23: Ferenchick HR, Chua AT, Carlese AJ, Shiloh AL. A Woman With Recent Stroke</p>
<p>Presenting With Respiratory Failure and Shock. Chest. 2018 May;153(5):e101-e103.</p>
<p>doi: 10.1016/j.chest.2017.11.048. PMID: 29731049.</p>
<p>&nbsp;</p>
<p>24: Savel RH, Shiloh AL, Simon RJ, Kupfer Y. Using Big Data to See the Big</p>
<p>Picture in Sepsis. Crit Care Med. 2018 Apr;46(4):640-641. doi:</p>
<p>10.1097/CCM.0000000000002976. PMID: 29538113.</p>
<p>&nbsp;</p>
<p>25: Kumarasamy N, Tishbi N, Mukundan S, Shiloh A, Levsky JM, Haramati LB.</p>
<p>Cardiothoracic MRI in the ICU: A 10-Year Experience. Acad Radiol. 2018</p>
<p>Mar;25(3):359-364. doi: 10.1016/j.acra.2017.09.017. Epub 2018 Feb 6. PMID:</p>
<p>29426683.</p>
<p>&nbsp;</p>
<p>26: Lishmanov A, Bellamkonda TT, Shiloh AL. A Woman in Her 20s With</p>
<p>Cardiopulmonary Failure. Chest. 2017 Jun;151(6):e123-e125. doi:</p>
<p>10.1016/j.chest.2017.01.040. PMID: 28599944.</p>
<p>&nbsp;</p>
<p>27: Shiloh AL, Sobolev M, Di Biase L, Slovut DP. A call for safety during</p>
<p>electrophysiological procedures: US in, why not US out? Authors' reply.</p>
<p>Europace. 2017 Dec 1;19(12):2048-2049. doi: 10.1093/europace/eux007. PMID:</p>
<p>28340047.</p>
<p>&nbsp;</p>
<p>28: Sobolev M, Shiloh AL, Di Biase L, Slovut DP. Ultrasound-guided cannulation</p>
<p>of the femoral vein in electrophysiological procedures: a systematic review and</p>
<p>meta-analysis. Europace. 2017 May 1;19(5):850-855. doi: 10.1093/europace/euw113.</p>
<p>PMID: 27207813.</p>
<p>&nbsp;</p>
<p>29: Shiloh AL, Lominadze G, Gong MN, Savel RH. Early Warning/Track-and-Trigger</p>
<p>Systems to Detect Deterioration and Improve Outcomes in Hospitalized Patients.</p>
<p>Semin Respir Crit Care Med. 2016 Feb;37(1):88-95. doi: 10.1055/s-0035-1570352.</p>
<p>Epub 2016 Jan 28. PMID: 26820276.</p>
<p>&nbsp;</p>
<p>30: Patrawalla P, Eisen LA, Shiloh A, Shah BJ, Savenkov O, Wise W, Evans L, Mayo</p>
<p>P, Szyld D. Development and Validation of an Assessment Tool for Competency in</p>
<p>Critical Care Ultrasound. J Grad Med Educ. 2015 Dec;7(4):567-73. doi:</p>
<p>10.4300/JGME-D-14-00613.1. PMID: 26692968; PMCID: PMC4675413.</p>
<p>&nbsp;</p>
<p>31: Hena KM, Eisen LA, Shiloh AL. A Man in His 60s With Renal Failure and Shock</p>
<p>Refractory to Vasopressors. Chest. 2015 Dec;148(6):e171-e174. doi:</p>
<p>10.1378/chest.15-0160. PMID: 26621295.</p>
<p>&nbsp;</p>
<p>32: Bernier-Jean A, Albert M, Shiloh AL, Eisen LA, Williamson D, Beaulieu Y. The</p>
<p>Diagnostic and Therapeutic Impact of Point-of-Care Ultrasonography in the</p>
<p>Intensive Care Unit. J Intensive Care Med. 2017 Mar;32(3):197-203. doi:</p>
<p>10.1177/0885066615606682. Epub 2016 Jul 9. PMID: 26423745.</p>
<p>&nbsp;</p>
<p>33: Shiloh AL, Adrish M. A Man in His 60s With Cirrhosis, Encephalopathy, and</p>
<p>Shock. Chest. 2015 Jul;148(1):e5-e7. doi: 10.1378/chest.14-2201. PMID: 26149567.</p>
<p>&nbsp;</p>
<p>34: Sobolev M, Slovut DP, Lee Chang A, Shiloh AL, Eisen LA. Ultrasound-Guided</p>
<p>Catheterization of the Femoral Artery: A Systematic Review and Meta-Analysis of</p>
<p>Randomized Controlled Trials. J Invasive Cardiol. 2015 Jul;27(7):318-23. PMID:</p>
<p>26136279.</p>
<p>&nbsp;</p>
<p>35: Adrish M, Shiloh AL. A woman in her 50s with recent coronary artery bypass</p>
<p>grafting presenting with right-sided chest pain. Chest. 2015</p>
<p>May;147(5):e171-e174. doi: 10.1378/chest.14-0457. PMID: 25940259.</p>
<p>&nbsp;</p>
<p>36: Shiloh AL, Ari Eisen L, Savel RH. The unplanned intensive care unit</p>
<p>admission. J Crit Care. 2015 Apr;30(2):419-20. doi: 10.1016/j.jcrc.2014.12.010.</p>
<p>Epub 2014 Dec 24. PMID: 25579373.</p>
<p>&nbsp;</p>
<p>37: Eisen LA, Savel RH, Shiloh AL. Video laryngoscopy in the intensive care</p>
<p>unit. A clearer view? Ann Am Thorac Soc. 2014 Oct;11(8):1254-5. doi:</p>
<p>10.1513/AnnalsATS.201408-386ED. PMID: 25343195.</p>
<p>&nbsp;</p>
<p>38: Chung M, Shiloh AL, Carlese A. Monitoring of the adult patient on</p>
<p>venoarterial extracorporeal membrane oxygenation. ScientificWorldJournal.</p>
<p>2014;2014:393258. doi: 10.1155/2014/393258. Epub 2014 Apr 3. PMID: 24977195;</p>
<p>PMCID: PMC3998007.</p>
<p>&nbsp;</p>
<p>39: Karakitsos D, El Barbary M, Gillman LM, Papalois A, Shiloh A. Critical care</p>
<p>and perioperative monitoring. ScientificWorldJournal. 2014;2014:737628. doi:</p>
<p>10.1155/2014/737628. Epub 2014 May 4. PMID: 24892082; PMCID: PMC4032705.</p>
<p>&nbsp;</p>
<p>40: Tischenkel BR, Gong MN, Shiloh AL, Pittignano VC, Keschner YG, Glueck JA,</p>
<p>Cohen HW, Eisen LA. Daytime Versus Nighttime Extubations: A Comparison of</p>
<p>Reintubation, Length of Stay, and Mortality. J Intensive Care Med. 2016</p>
<p>Feb;31(2):118-26. doi: 10.1177/0885066614531392. Epub 2014 Apr 24. PMID:</p>
<p>24763118.</p>
<p>&nbsp;</p>
<p>41: Shiloh AL, Kazzi MG, Mathew R, Eisen LA, Carlese AJ. A man in his 40s with a</p>
<p>history of hypertension and alcohol dependency presenting to the ED with</p>
<p>respiratory distress: septic shock in the setting of ARDS. Chest. 2014</p>
<p>Feb;145(2):e3-e6. doi: 10.1378/chest.13-2089. PMID: 24493554.</p>
<p>&nbsp;</p>
<p>42: Shiloh AL, Sobolev M, Eisen LA. A woman in her 30s in respiratory distress</p>
<p>with a history of gestational diabetes and hypertension. Chest. 2014</p>
<p>Jan;145(1):e1-e2. doi: 10.1378/chest.13-1850. PMID: 24394849.</p>
<p>&nbsp;</p>
<p>43: Lahiri S, Boro AD, Shiloh AL, Milstein MJ, Savel RH. Periodic Epileptiform</p>
<p>Discharges Clarified for the Nonneurologist Intensivist: Clinical Implications</p>
<p>and Current Management. J Intensive Care Med. 2015 Oct;30(7):385-91. doi:</p>
<p>10.1177/0885066613513411. Epub 2013 Dec 9. PMID: 24323590.</p>
<p>&nbsp;</p>
<p>44: Eisen LA, Janowski W, Shiloh AL. Ultrasound diagnosis of shock in a woman</p>
<p>with metastatic renal cell carcinoma. Chest. 2013 Sep;144(3):e1-e3. doi:</p>
<p>10.1378/chest.13-0964. PMID: 24008972.</p>
<p>&nbsp;</p>
<p>45: Savel RH, Shiloh AL, Eisen LA. Tackling the tough questions: what was this</p>
<p>patient like before they were critically ill? Crit Care Med. 2013</p>
<p>Jan;41(1):327-8. doi: 10.1097/CCM.0b013e318267a8ad. PMID: 23269133.</p>
<p>&nbsp;</p>
<p>46: Shiloh AL, Eisen LA, Yee M, Langner JB, LeDonne J, Karakitsos D. Ultrasound-</p>
<p>guided subclavian and axillary vein cannulation via an infraclavicular approach:</p>
<p>In the tradition of Robert Aubaniac. Crit Care Med. 2012 Oct;40(10):2922-3. doi:</p>
<p>10.1097/CCM.0b013e31825cea64. PMID: 22986669.</p>
<p>&nbsp;</p>
<p>47: Keene AB, Shiloh AL, Dudaie R, Eisen LA, Savel RH. Online testing from</p>
<p>Google Docs&trade; to enhance teaching of core topics in critical care: a pilot study.</p>
<p>Med Teach. 2012;34(12):1075-7. doi: 10.3109/0142159X.2012.716553. Epub 2012 Aug</p>
<p>30. PMID: 22931149.</p>
<p>&nbsp;</p>
<p>48: Stefanidis K, Pentilas N, Dimopoulos S, Nanas S, Savel RH, Shiloh AL,</p>
<p>Poularas J, Slama M, Karakitsos D. Echogenic Technology Improves Cannula</p>
<p>Visibility during Ultrasound-Guided Internal Jugular Vein Catheterization via a</p>
<p>Transverse Approach. Crit Care Res Pract. 2012;2012:306182. doi:</p>
<p>10.1155/2012/306182. Epub 2012 May 10. PMID: 22649715; PMCID: PMC3357505.</p>
<p>&nbsp;</p>
<p>49: Stefanidis K, Fragou M, Pentilas N, Kouraklis G, Nanas S, Savel RH, Shiloh</p>
<p>AL, Slama M, Karakitsos D. Optimization of Cannula Visibility during Ultrasound-</p>
<p>Guided Subclavian Vein Catheterization, via a Longitudinal Approach, by</p>
<p>Implementing Echogenic Technology. Crit Care Res Pract. 2012;2012:617149. doi:</p>
<p>10.1155/2012/617149. Epub 2012 Apr 23. PMID: 22593825; PMCID: PMC3347863.</p>
<p>&nbsp;</p>
<p>50: Savel RH, Shiloh AL, Eisen LA. Educational impact of continuous chest</p>
<p>compression cardiopulmonary resuscitation: the confidence to "pay it forward"*.</p>
<p>Crit Care Med. 2012 Mar;40(3):992-3. doi: 10.1097/CCM.0b013e31823878b1. PMID:</p>
<p>22343848.</p>
<p>&nbsp;</p>
<p>51: Shiloh AL, Eisen LA, Savel RH. Goal-directed ultrasonography in the</p>
<p>intensive care unit: no more excuses! Crit Care Med. 2011 Apr;39(4):879-80. doi:</p>
<p>10.1097/CCM.0b013e318208e393. PMID: 21613832.</p>
<p>&nbsp;</p>
<p>52: Rosenberg JB, Shiloh AL, Savel RH, Eisen LA. Non-invasive methods of</p>
<p>estimating intracranial pressure. Neurocrit Care. 2011 Dec;15(3):599-608. doi:</p>
<p>10.1007/s12028-011-9545-4. PMID: 21519957.</p>
<p>&nbsp;</p>
<p>53: Kory PD, Pellecchia CM, Shiloh AL, Mayo PH, DiBello C, Koenig S. Accuracy of</p>
<p>ultrasonography performed by critical care physicians for the diagnosis of DVT.</p>
<p>Chest. 2011 Mar;139(3):538-542. doi: 10.1378/chest.10-1479. Epub 2010 Oct 28.</p>
<p>PMID: 21030490.</p>
<p>&nbsp;</p>
<p>54: Shiloh AL, Savel RH, Paulin LM, Eisen LA. Ultrasound-guided catheterization</p>
<p>of the radial artery: a systematic review and meta-analysis of randomized</p>
<p>controlled trials. Chest. 2011 Mar;139(3):524-529. doi: 10.1378/chest.10-0919.</p>
<p>Epub 2010 Aug 19. PMID: 20724734.</p>
<p>&nbsp;</p>
<p>55: Shiloh AL, Eisen LA, Savel RH. Selective decontamination of the digestive</p>
<p>tract: what outcomes matter? Crit Care Med. 2010 May;38(5):1386-7. doi:</p>
<p>10.1097/CCM.0b013e3181da47d1. PMID: 20404637.</p>
<p>&nbsp;</p>
<p>56: Shiloh AL, Eisen LA. Ultrasound-guided arterial catheterization: a narrative</p>
<p>review. Intensive Care Med. 2010 Feb;36(2):214-21. doi:</p>
<p>10.1007/s00134-009-1699-6. Epub 2009 Oct 31. PMID: 19882140.</p>
<p>&nbsp;</p>
<p>57: Li M, Chen D, Shiloh A, Luo J, Nikolaev AY, Qin J, Gu W. Deubiquitination of</p>
<p>p53 by HAUSP is an important pathway for p53 stabilization. Nature. 2002 Apr</p>
<p>11;416(6881):648-53. doi: 10.1038/nature737. Epub 2002 Mar 31. PMID: 11923872.</p>

EMR ID

4723

Biography

<p>Ariel L Shiloh, MD, is Director, Critical Care Consult Services, Professor, Medicine and Associate Professor, Neurology at Montefiore Einstein. Dr. Shiloh&rsquo;s clinical interests include the early detection and treatment of critical illness, point-of-care ultrasonography for the evaluation of critical illness and advanced airway management.</p><p>After earning his Bachelor of Arts from Yeshiva University, Dr. Shiloh attended the Medical School for International Health at Ben Gurion University, Be&rsquo;er Sheva, Israel, earning his Doctor of Medicine in 2005. He came to Montefiore for his postdoctoral training, completing his internship and residency in internal medicine in 2008, followed by his fellowship in critical care medicine in 2010.</p><p>Dr. Shiloh's research includes the clinical use of point-of-care ultrasonography in critical illness, improvement of airway management, and cardiopulmonary resuscitation. He has shared his work through peer-reviewed journals, invited presentations, books, abstracts and poster presentations at national conferences. He has also been a reviewer for several journals including <em>Chest</em>, the <em>American Journal of Critical Care</em> and the <em>European Journal of Anesthesiology</em>.</p><p>Dr. Shiloh is board certified in Internal Medicine, Critical Care Medicine and Neurocritical Care and Hospice &amp; Palliative Medicine. He is a Fellow of the American College of Chest Physicians and a member of the Society of Critical Care Medicine. Dr. Shiloh has been recognized by the American College of Chest Physicians as a Distinguished CHEST Educator, among the top 5% of CHEST&rsquo;s international faculty recognized for long-term contributions to the design and delivery of CHEST education</p>

Is Open Scheduling

Off

Theresa M. Serra

https://assets.montefioreeinstein.org/profiles/images/Serra_Theresa_MD_2x.jpg

First Name

Theresa

Last Name

Serra

NPI

1609164078

Faculty ID

14280

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Clinical Focus

Pediatric Medicine

Elsevier Profile

EMR ID

55674

Biography

<p class="MsoNormal">Theresa Serra, MD, joined the CHAM hospitalist division in 2014 after working as a pediatric hospitalist at New York Presbyterian/Lower Manhattan Hospital. Her interests include clinical research and medical education. She has conducted an IRB approved retrospective chart review examining readmission rates in pediatric patients diagnosed with osteomyelitis. Dr. Serra is currently developing a medical Spanish curriculum for faculty members in order to improve communication between patients, families and providers. Along with Courtney McNamara, MD, Dr. Serra is a co-leader of a multidisciplinary committee dedicated to standardizing and improving quality of care for patients hospitalized with the diagnosis of failure to thrive. Dr. Serra is also working on an initiative to identify vaccine delinquency in the inpatient setting through the use of SMART reports.</p> <p class="MsoNormal">Dr. Serra is also collaborating with Lindsey Douglas, MD, MSCR, in an IRB approved quality improvement (QI) project to improve transition-of-care communication between hospitalists and primary care providers and to facilitate the establishment of medical homes. Dr. Serra is also a member of a subcommittee that leads monthly journal clubs/case conferences for pediatric hospitalists.</p>

Is Open Scheduling

Off

Adarsha Selvachandran

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/b851f490-5fb9-11ec-9773-d197dc92a0d8.jpg

First Name

Adarsha

Last Name

Selvachandran

NPI

1134578248

Faculty ID

16723

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

87590

Is Open Scheduling

Off

Scott J. Schafler

https://assets.montefioreeinstein.org/profiles/images/Scott-Schafler.jpg

First Name

Scott

Last Name

Schafler

NPI

1417219585

Faculty ID

16440

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

55639

Is Open Scheduling

Off

Alexander I. Sankin

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/6a135040-3a87-11ed-8158-59ecbd24247c.jpg

First Name

Alexander

Last Name

Sankin

NPI

1982866570

Faculty ID

14891

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Sankin is an academic surgeon in the Department of Urology, at Montefiore Medical Center with a clinical focus on surgical approaches to the management of urologic malignancies of the upper urinary tract and bladder. His academic focus is divided between clinical and translational research studying emerging treatments and techniques central to the surgical care of patients with urologic cancers.&nbsp;</p>
<p>Dr. Sankin is the site-Principal Investigator for multiple clinical trials studying novel therapeutics for patients with bladder cancer who wish to avoid radical cystectomy. As an active member of multiple clinical trial consortiums including Eastern Cooperative Oncology Group and the Society of Urologic Oncology Clinical Trials Consortium, Dr. Sankin speardeaded the development of a bladder cancer clinical trials program at Einstein.&nbsp;</p>
<p>His translational research focuses on characterizing the tumor immune microenvironment of bladder tumors and the role of novel checkpoint molecules as relevant therpeutic targets. &nbsp;</p>
<p>&nbsp;</p>

Research Areas

Expert Tags

Areas of Expertise

Expert Summary

<p>Dr. Sankin current research program focuses on the translational application of immune-oncology to the treatment of urologic cancer.</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Dr. Sankin's&nbsp;clinical specialty is surgical approaches to treating urological malignancies, including prostate, testicular, renal and bladder cancer.<quillbot-extension-portal></quillbot-extension-portal>

Research Focus

Building on his clinical focus, Dr. Sankin&rsquo;s research centers on bladder-preserving treatment options in patients with high-risk bladder cancer and the development of new immunotherapies for bladder cancer.&nbsp;<quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

Selected Publications

<p align="left">Clark TW,&nbsp;Sankin A, Becske T, Nelson PK, Fox M.&nbsp;&nbsp;Stent-assisted Gugliemi detachable coil repair of wide-necked renal artery aneurysm using 3-D angiography.&nbsp;&nbsp;Vasc Endovascular Surg 2008 Jan; 41(6):528-32</p>
<p align="left">Tareen B,&nbsp;Sankin A, Godoy G, Temkin S, Lepor H, Taneja SS.&nbsp;Appropriate candidates for hemiablative focal therapy are infrequently encountered among men selected for radical prostatectomy in contemporary cohort<em>.</em>&nbsp;Urology.&nbsp;&nbsp;2009 Feb;73(2):351-4</p>
<p align="left">Tareen B, Godoy G,&nbsp;Sankin A, Temkin S, Lepor H, Taneja SS.&nbsp;&nbsp;Laterality alone should not drive selection of candidates for hemi-ablative focal therapy.&nbsp;J Urol.&nbsp;&nbsp;2009 Mar;181(3):1082-9</p>
<p align="left">Tareen B, Godoy G,&nbsp;Sankin A, Temkin S, Lepor H, Taneja SS.&nbsp;&nbsp;Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer?&nbsp;&nbsp;BJU Int. 2009 Jul;104(2):195-9</p>
<p align="left">Marien T,&nbsp;Sankin A, Lepor H.&nbsp;&nbsp;Factors predicting preservation of erectile function in men undergoing open radical retropubic prostatectomy.&nbsp;&nbsp;J Urol.&nbsp;&nbsp;2009 Apr;181(4):1817-22</p>
<p align="left">Sankin A, Tareen B, Lepor H.&nbsp;&nbsp;Side-specific factors associated with extracapsular extension and seminal vesicular invasion in men undergoing open radical retropubic prostatectomy.&nbsp;&nbsp;Prostate Cancer Prostatic Dis.&nbsp;&nbsp;2009;12(2):204-8</p>
<p align="left">Mufarrij P,&nbsp;Sankin A, Godoy G, Lepor H.&nbsp;Pathologic outcomes of candidates for active surveillance undergoing radical prostatectomy.&nbsp;&nbsp;Urology.&nbsp;&nbsp;2010 Sep;76(3):689-92</p>
<p align="left">Sankin A, Cohen J, Wang H, Macchia RJ, Karanikolas N.&nbsp;&nbsp;Rate of renal cell carcinoma subtypes in different races.&nbsp;&nbsp;Int Braz J Urol.&nbsp;&nbsp;2011 Feb;37(1):29-32</p>
<p align="left">Sankin A, Sfakianos J, Schiff J, Sjoberg D, Coleman J.&nbsp;Assessing renal function following partial nephrectomy using renal nuclear scintigraphy and eGFR.&nbsp;&nbsp;Urology.&nbsp;&nbsp;2012 Aug;80(2):343-6</p>
<p align="left">Ghavamian R, Hakimi AA, Williams SK, Kim PH, Chen L, Sfakianos JP, Keren-Paz GE,&nbsp;Sankin A,&nbsp;Ginzburg N, Coleman JA.&nbsp;&nbsp;Factors affecting proportional glomerular filtration rate following minimally invasive partial nephrectomy.&nbsp;&nbsp;J Endourology&nbsp;&nbsp;2013 Nov;27(11):1371-5</p>
<p align="left">Sankin A, Hakimi AA, Mikkilineni N, Ostrovnaya I, Silk MT, Liang Y, Mano R, Chevinsky M, Motzer RJ, Solomon SB, Cheng EH, Durack JC, Coleman JA, Russo P, Hsieh JJ.&nbsp;&nbsp;The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional sampling.&nbsp;&nbsp;Cancer Medicine 2014 Dec;3(6):1485-92</p>
<p align="left">Mano R, Vertosick E,&nbsp;Sankin A,&nbsp;Chevinsky M, Larish Y, Jakubowski CD, Hotker AM, Sjoberg D, Akin O, Russo P.&nbsp;&nbsp;The clinical significance of indeterminate pulmonary nodules in patients with renal cell carcinoma.&nbsp;&nbsp;J Urol 2014 Mar;193(3):776-82</p>
<p align="left">Chevinsky M, Imnadze M,&nbsp;Sankin A, Winer A, Mano R, Jakubowski C, Mashni J, Sjoberg DD, Chen YB, Tickoo SK, Reuter VE, Hakimi AA, Russo P.&nbsp;Pathologic stage T3a significantly increases disease recurrence across all tumor sizes in renal cell carcinoma.&nbsp;J Urol 2015 Aug;194(2):310-5</p>
<p align="left">Hakimi AA, Tickoo S, Jacobsen A, Sarungbam J, Sfakianos J, Sato Y, Morikawa T, Kume H, Fukayama M, Homma Y, Chen YB,&nbsp;Sankin A,&nbsp;Mano R, Coleman JA, Russo P, Ogawa S, Sander C, Hsieh JJ, Reuter VE.&nbsp;TCEB1-mutated renal cell carcinoma: a distinct genomic and morphologic subtype.&nbsp;&nbsp;Mod Pathol 2015 June;28(6):845-53</p>
<p align="left">Sankin A,&nbsp;Hakimi AA, Hsieh JJ, Molina AM.&nbsp;&nbsp;Metastatic non-clear cell renal cell carcinoma: an evidence based review of current treatment strategies.&nbsp;&nbsp;Front Oncol 2015 Apr 8;5:67</p>
<p align="left">Hakimi AA, Ostrovnaya I, Jacobsen A, Susztak K, Coleman JA, Russo P, Winer AG, Mano R,&nbsp;Sankin A, Motzer RJ, Voss MH, Offit K, Purdue M, Pomerantz M, Freedman M, Choueiri TK, Hsieh JJ, Klein RJ.&nbsp;&nbsp;Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell&nbsp;carcinoma.&nbsp;&nbsp;Cancer 2016 Feb 1;122(3):402-10</p>
<p align="left">Sankin A. Discovering biomarkers within the genomic landscape of renal cell carcinoma.&nbsp;&nbsp;J Kidney 2016 Feb 2(1)&nbsp;</p>
<p align="left">Sankin A, Tin A, Mano R, Chevinsky M, Jakubowski C, Cha E, Yee A, Friedman F, Sjoberg D, Ehdaie B, Coleman J.&nbsp;&nbsp;Impact of ureteroscopy prior to nephroureterectomy for upper tract urothelial carcinoma on oncologic outcomes.&nbsp;&nbsp;Urology 2016 Aug; 94:148-53</p>
<p align="left">Mano R, Hakimi AA,&nbsp;Sankin AI,&nbsp;Sternberg IA, Chevinsky MS, Russo P.&nbsp;&nbsp;Surgical treatment of tumors involving kidneys with fusion anomalies &ndash; a contemporary series.&nbsp;&nbsp;Urology 2016 Aug; 98:97-102</p>
<p align="left">Zhou TC,&nbsp;Sankin A,&nbsp;Porcelli SA, Perlin DS, Schoenberg MP, Zang XX.&nbsp;&nbsp;A review of the PD-1/PD-L1 checkpoint in bladder cancer: from mediator of immune escape, to target for treatment.&nbsp;&nbsp;Urol Oncol 2017 Jan;35(1):14-20&nbsp;</p>
<p align="left">Winer AG, Vertosick EA, Ghanaat M, Corradi RB, Carlsson S, Sjoberg DD,&nbsp;Sankin AI,&nbsp;Sfakianos JP, Cha EK, Dalbagni G, Coleman JA.&nbsp;Prognostic value of lymph node yield during nephroureterectomy for upper tract urothelial carcinoma.&nbsp;&nbsp;Urol Oncol 2017 April;35(4):151</p>
<p align="left">Sankin&nbsp;A,&nbsp;Narasimhulu&nbsp;D, John P,&nbsp;Gartrell&nbsp;B, Schoenberg M, Zang XX.&nbsp; The expanding repertoire of targets for immune checkpoint inhibition in bladder cancer: what lies beneath the tip of the iceberg, PD-L1.&nbsp;&nbsp;Urol&nbsp;Onc&nbsp;2017 (Epub ahead of print)</p>
<p align="left">Milbar N, Kates M, Chappidi MR, Pederzoli F, Yoshida T,&nbsp;Sankin A,&nbsp;Pierorazio PM, Schoenberg MP, Bivalacqua TJ. Oncological outcomes of sequential intravesical gemcitabine and docetaxel in patients with non-muscle invasive bladder cancer.&nbsp;&nbsp;Bladder Cancer 2017 Oct 27;3(4):293-303</p>
<p align="left">Daneshmand S, Patel s, Lotan Y, Pohar K, Trabulsi E, Woods M, Downs T, Huang W, Jones J, O&rsquo;Donnell M, Bivalacqua T, DeCastro J, Steinberg G, Kamat A, Resnick M, Konety B, Schoenberg M, Jones JS,&nbsp;Flexible Blue Light Study Group Collaborators.&nbsp;Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study.&nbsp;&nbsp;J Urol 2018 May;199(5):1158-65</p>
<p align="left">Fridman D, Abeshouse M,&nbsp;Sankin A.&nbsp;Paraurethral Leiomyoma as an Incidental Finding in a Patient with Fibroid Uterus. Case Rep Obstet Gynecol 2018 Feb 7;2018</p>
<p align="left">Adrianzen Hererra DA, Goldberg-Stein S,&nbsp;Sankin A, Sarungbam J, Sharma J, Gartrell BA. Synchronous Bone Metastasis From Multiple Myeloma and Prostate Adenocarcinoma as Initial Presentation of Coexistent Malignancies. Front Oncol, 2018 Apr 30;8:137</p>
<p align="left">Berstein A, Fram EB,&nbsp;Sankin A, Kovac E, Srivastava A, DiVito J, Stern JM. A Comparison of Perinephric Fat Surface Area and Mayo Adhesive Probability Score in Predicting Malignancy in T1 Renal Masses.&nbsp;&nbsp;Urol Onc 2018 Nov; 36(11):499</p>
<p align="left">Sun Y, Reuter VE, Magi-Galluzzi C,&nbsp;Sankin A,&nbsp;Epstein JI.&nbsp;Granular Cell Tumor of the Bladder: A Report of Six Cases.&nbsp;&nbsp;Urology 2018 Nov; 121:203&nbsp;</p>
<p align="left">Leow JJ, Bedke J, Chamie K, Collins JW, Daneshmand S, Grivas P, Heidenreich A, Messing EM, Royce TJ,&nbsp;Sankin A,&nbsp;Schoenberg MP, Shipley WU, Villers A, Efstathiou J, Bellmunt J, Stenzl A.&nbsp;&nbsp;Recommendations From Joint SIU-ICUD Consultation On Bladder Cancer: Muscle-Invasive Presumably Regional Tumor.&nbsp;&nbsp;World J Urol 2019, Jan;37(1): 61-83</p>
<p align="left">Chand D, Dhawan D,&nbsp;Sankin A, Ren X, Lin J, Schoenberg M, Knapp DW, Zang X. Immune checkpoint B7x (B7-H4/B7S1/VtCN1) is overexpressed in spontaneous canine bladder cancer: the first report and its implications in a preclinical model. Bladder Cancer 2019, Jan 31;5(1)63-71</p>
<p align="left">Bernstein A, Barry E, Fram EB,&nbsp;Sankin A,&nbsp;Kovac E, Stern JM.&nbsp;Does Glomerular Filtration Rate at Discharge After Partial Nephrectomy Predict Long-Term Glomwerular Filtration Rate Stability?. J Endourol 2019, Jun;33(6):488-491</p>
<p align="left">Lotan Y, Bivalacqua TJ, Downs T, Huang W, Jones J, Kamat A, Konety B, Malmstrom PU, McKiernan J, O&rsquo;Donnell M, Patel S, Pohar K, Resnick M,&nbsp;Sankin A,&nbsp;Smith A, Steinberg G, Trabulsi E, Woods M, Daneshmand S.&nbsp;&nbsp;Blue light flexible cystoscopy with hexaminolevulinate in non-muscle invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA &ndash; update 2018. Nat Rev Urol 2019, Jun;16(6):377-386</p>
<p align="left">Sankin A,&nbsp;Chand D, Schoenberg M, Zang X.&nbsp;&nbsp;Human urothelial bladder cancer generates a clonal immune response: the results of T-cell receptor sequencing.&nbsp;&nbsp;Urol Oncol 2019, May 15 (epub ahead of print).</p>
<p align="left">Wang H, Kaur G,&nbsp;Sankin A,&nbsp;Chen F, Guan F, Zang X.&nbsp;Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies.&nbsp;&nbsp;J Hematol Oncol 2019, Jun 11;12(1):59</p>
<p align="left">Daniels MJ, Barry E, Schoenberg M, Lamm DL, Bivalacqua TJ,&nbsp;Sankin A, Kates M.&nbsp;&nbsp;Contemporary oncologic outcomes of second induction course BCG in patients with nonmuscle invasive bladder cancer. Urol Oncol 2019, Jun 26 (epub ahead of print)</p>
<p align="left">Daniels MJ, Barry E, Milbar N, Schoenberg M, Bivalacqua TJ,&nbsp;Sankin A, Kates M. An evaluation of monthly maintenance therapy among patients receiving intravesical combination gemcitabine/docetaxel for nonmuscle invasive bladder cancer.&nbsp;&nbsp;Urol Oncol 2019, Aug 28 (epub ahead of print)</p>
<p align="left">Khaki AR, Li A, Diamantopoulos LN, Bilen MA, Santos V, Esther J, Morales-Barrera R, Devitt M, Nelson A, Holmes CJ, Shreck E, Assi H, Gartrell BA, Sankin A,&nbsp;Rodriguez-Vida A, Lythgoe M, Pinato DJ, Drakaki A, Joshi M, Isaacsson Velho P, Hahn N, Liu S, Alonso Buznego L, Duran I, Moses M, Jain J, Murgic J, Baratam P, Barata P, Tripathi A, Zakharia Y, Galsky MD, Sonpavde G, Yu EY, Shankaran V, Lyman GH, Grivas P.&nbsp;&nbsp;Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with checkpoint inhibitors.&nbsp;&nbsp;Cancer 2019, Dec 12 (epub ahead of print)</p>

EMR ID

78143

Biography

<p>Alexander I. Sankin, MD, is Associate Professor, Urology at Montefiore Einstein. His clinical specialty is surgical approaches to treating urological malignancies, including prostate, testicular, renal and bladder cancer.</p><p>After earning his Master of Science from the University of Pennsylvania in 2004, Dr. Sankin earned his Doctor of Medicine from New York University in 2008 and completed his residency in surgery and urology at the State University of New York Downstate in 2013. He then completed a fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center in 2015.</p><p>Building on his clinical focus, Dr. Sankin&rsquo;s research centers on bladder-preserving treatment options in patients with high-risk bladder cancer and the development of new immunotherapies for bladder cancer. He is the site-principal investigator for multiple clinical trials studying novel therapeutics for patients with bladder cancer who wish to avoid radical cystectomy. As an active member of multiple clinical trial consortiums, including Eastern Cooperative Oncology Group and the Society of Urologic Oncology Clinical Trials Consortium, Dr. Sankin spearheaded the development of a bladder cancer clinical trials program at Einstein. His translational research focuses on characterizing the tumor immune microenvironment of bladder tumors and the role of novel checkpoint molecules as relevant therapeutic targets. His work has been published in numerous peer-reviewed journals.</p><p>Dr. Sankin is board certified and a member of the American Urological Association and the Society of Urologic Oncology.</p>

Is Open Scheduling

Off

Orna Rosen

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/52f35570-35f2-11ed-8123-8ffce84a9f6a.jpg

First Name

Orna

Last Name

Rosen

NPI

1205912151

Faculty ID

1126

CMO Specialties

Clinical Terms

Employment Status

part-time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

3910

Is Open Scheduling

Off

Evelyn M. Rondinel

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/31d12950-3cae-11ec-9e23-c5d5559390c7.jpg

First Name

Evelyn

Last Name

Rondinel

NPI

1821138702

Faculty ID

18003

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Languages

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

4488

Is Open Scheduling

Off

Kimberly J. Reidy

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/3968bb50-3ab5-11ed-8158-59ecbd24247c.jpg

First Name

Kimberly

Last Name

Reidy

NPI

1760652556

Faculty ID

10200

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Languages

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Elsevier Profile

EMR ID

4390

Biography

<p>Kimberly J. Reidy, MD, is Chief, Division of Pediatric Nephrology and Associate Professor at Children&rsquo;s Hospital at Montefiore (CHAM) and Montefiore Einstein. Her clinical focus is on the treatment of hypertension and childhood-onset kidney disease. She has particular interest in nephrotic syndrome and glomerular diseases, congenital abnormalities of the kidney and urinary tract, and genetic kidney diseases.</p><p>After earning her Bachelor of Arts in chemistry at Princeton University in 1997, Dr. Reidy attended Albert Einstein College of Medicine, earning her Doctor of Medicine in 2002. Her postdoctoral training began with a pediatric internship and residency at Children&rsquo;s Hospital of New York, NewYork-Presbyterian from 2002 to 2005. She then pursued a three-year National Institutes of Health (NIH) supported fellowship in pediatric nephrology at CHAM, completing it in 2008.</p><p>Dr. Reidy&rsquo;s clinical research focuses on children with glomerular and chronic kidney disease, including NIH funded Nephrotic Syndrome Study Network (NEPTUNE) and Cure Glomerulonephropathy (CureGN) studies of children with nephrotic syndrome. Her translational research focuses on the effect of APOL1 risk variants on preeclampsia and perinatal outcomes. Her bench research focuses on effects of developmental genes on kidney repair and fibrosis after injury. She has shared her work through many peer-reviewed journals, invited presentations, book chapters and abstracts. Dr. Reidy is also an ad hoc reviewer for many journals including <em>Pediatric Nephrology, Kidney International and the Journal of the American Society of Nephrology</em>.</p><p>Dr. Reidy is board-certified in pediatrics and pediatric nephrology. She is an active member of several professional organizations including the American Society of Pediatric Nephrology, the American Academy of Pediatrics (AAP) and the Neonatal Kidney Collaborative. She currently serves on the Executive Committee of the Section of Nephrology for the AAP. From 2016 through 2021, she has been listed among Castle Connolly Top Doctors: New York Metro Area. In 2021, she was elected to membership in the Leo M. Davidoff Society, recognizing her long-term commitment to excellence in teaching medical students.</p>

Is Open Scheduling

Off

Samuel J. Rednor

https://assets.montefioreeinstein.org/profiles/images/default-profile-blue.svg

First Name

Samuel

Last Name

Rednor

NPI

1265775167

Faculty ID

16224

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Nephrology and Critical Care.

Research Focus

Dr. Rednor&rsquo;s research focus is in acute kidney injury (AKI), cardiac arrest, and intubation.&nbsp;

Elsevier Profile

EMR ID

87716

Biography

<p>Samuel J. Rednor, DO, is Director of Wellness, Critical Care and Assistant Professor, Medicine at Montefiore Einstein. His clinical focus is nephrology and critical care.</p><p>After earning his Doctor of Osteopathic Medicine at Lake Erie College of Osteopathic Medicine in 2013, Dr. Rednor completed his residency in internal medicine at Southampton Hospital in 2016, where he was Chief Resident for one year. He then completed his renal fellowship at Montefiore in 2018, where he was Chief Renal Fellow during his last year. Dr. Rednor went on to complete an additional fellowship at Montefiore in critical care, which he completed in 2019.</p><p>Dr. Rednor&rsquo;s research focus is in acute kidney injury (AKI), cardiac arrest, and intubation. His work has been published in peer-reviewed journals and he has given multiple lectures and presentations.</p><p>Dr. Rednor is board certified in Internal Medicine, Nephrology and Critical Care Medicine by the American Osteopathic Board of Internal Medicine. He is a member of the American Society of Nephrology (ASN), the American Osteopathic Association (AOA), the Society of Critical Care Medicine (SCCM) and the American College of Chest Physicians (CHEST). In 2018, Dr. Rednor won the Sharon R. Silbiger Teaching Award for excellence in teaching and in recognition as Outstanding Fellow of the Year from Einstein.</p>

Is Open Scheduling

Off